Silvia Vicenzi/LinkedIn
Dec 29, 2025, 23:55
Silvia Vicenzi: From a Hormone-Centric Model to an Immune-Centric Understanding of the Disease
Silvia Vicenzi, Business Development Manager at Biocytogen, posted on LinkedIn:
“The kind of science we need more of: rigorous, human, and deeply purpose-driven. The latest Science feature on endometriosis research highlights a critical shift in the field: from a hormone-centric model to an immune-centric understanding of the disease.

Emerging data show that endometriotic lesions are shaped by:
- immune dysregulation (macrophage activation, altered NK cell function)
- chronic inflammatory signaling (IL-6, TNF-α, prostaglandins)
- aberrant tissue remodeling and angiogenesis
- immune–epithelial cross-talk driving lesion persistence
This reframes endometriosis as a complex immuno-inflammatory disorder, not just a reproductive one.
Why this matters:
- It opens the door to non-hormonal interventions that target pathways like inflammation, cytokine signaling, or immune cell recruitment.
- It supports development of diagnostic biomarkers based on immune signatures instead of invasive surgery.
- It aligns endometriosis with broader patterns seen in autoimmune-adjacent diseases.
Women’s health research is finally gaining the scientific attention it deserves — and immunology is at the center of that shift.
If you want to read the entire article here.”
Get insights from Hemostasis Today.
-
Sep 2, 2026, 09:52Rick Matthews: Expanding Mechanical Thrombectomy to Coronary Arteries
-
Sep 2, 2026, 09:49Yara Dixon: Barriers and Facilitators to Blood Donation Across Diverse Populations
-
Sep 2, 2026, 09:29Ana Sachetto: Liver Injury and Tissue Factor-Driven Coagulation
-
Sep 2, 2026, 09:28Kavya Keerthana: A Potentially Important Advance in Polycythemia Vera
-
Sep 2, 2026, 09:26Mohammad Zuryan: Pre-Marital Genetic Screening for Thalassemia Prevention
-
Sep 2, 2026, 09:23Mohammed Salman: 9 Key Changes in the Fifth Universal Definition of Myocardial Infarction
-
Sep 2, 2026, 07:02Christoph B. Olivier: Rapid Platelet Inhibition in Acute Coronary Syndromes
-
Sep 2, 2026, 06:38Gene Therapy for Glanzmann Thrombasthenia – Glanzmann’s Research Foundation
-
Sep 2, 2026, 06:32Sanjay Batra: Exploring What Lies Beyond Platelet Counts